Ann Moore
Nurse Practitioner · Glendale, AZNPI 1184840712
Payments from drug & device makers
Across 1,180 payments — averaging $1777.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$1.5M
- Novo Nordisk AS$309K
- Gilead$69K
- Corcept Therapeutics$66K
- Intercept Pharmaceuticals, Inc.$44K
- AbbVie$41K
- plus $57K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 227 | $1,510,764 |
| Novo Nordisk AS | 345 | $309,327 |
| Gilead | 177 | $68,682 |
| Corcept Therapeutics | 36 | $66,416 |
| Intercept Pharmaceuticals, Inc. | 84 | $44,214 |
| AbbVie | 148 | $40,669 |
| Ipsen Biopharmaceuticals, Inc | 51 | $23,933 |
| GSK | 11 | $15,923 |
| Siemens Medical Solutions USA, Inc. | 7 | $7,010 |
| Novo Nordisk | 7 | $3,810 |
| Albireo Pharma, Inc. | 2 | $2,888 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 36 | $1,603 |
| Ipsen Innovation | 1 | $665 |
| Amgen | 23 | $499 |
| Orphalan Inc | 4 | $97 |
| AstraZeneca | 3 | $75 |
| Mirum Pharmaceuticals, Inc. | 3 | $67 |
| Eisai Inc. | 3 | $55 |
| Boston Scientific | 2 | $48 |
| Merck | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Trisalus Life Sciences, Inc. | 1 | $25 |
| W. L. Gore & Associates, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Exelixis Inc. | 1 | $23 |
| Intra-sana Laboratories | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
How this compares
$2,096,980 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Glendale
- Ronalyn BaricevicGlendale$12K
- Shayla JohnsonGlendale$9K
- Bea Paula SalvaneraGlendale$9K
- Andrea KesslerLitchfield Park$780K
- Sandra KurtinTucson$201K
- Kristen HerzogScottsdale$162K
- Krista ArredondoChandler$133K
- Shannon MorgensternOro Valley$71K
- Helena In't VeldPhoenix$64K
- Steven KalfusChandler$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.